118 related articles for article (PubMed ID: 8896924)
1. Normal thymic uptake of FDG on PET imaging.
Patel PM; Alibazoglu H; Ali A; Fordham E; LaMonica G
Clin Nucl Med; 1996 Oct; 21(10):772-5. PubMed ID: 8896924
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of primary mediastinal tumours.
Kubota K; Yamada S; Kondo T; Yamada K; Fukuda H; Fujiwara T; Ito M; Ido T
Br J Cancer; 1996 Apr; 73(7):882-6. PubMed ID: 8611400
[TBL] [Abstract][Full Text] [Related]
3. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
4. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Gritters LS; Francis IR; Zasadny KR; Wahl RL
J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
[TBL] [Abstract][Full Text] [Related]
5. Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose.
Alibazoglu H; Alibazoglu B; Hollinger EF; Ingram SA; Willoughby WA; LaMonica G; Ali A
Clin Nucl Med; 1999 Aug; 24(8):597-600. PubMed ID: 10439182
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Shulkin BL; Hutchinson RJ; Castle VP; Yanik GA; Shapiro B; Sisson JC
Radiology; 1996 Jun; 199(3):743-50. PubMed ID: 8637999
[TBL] [Abstract][Full Text] [Related]
7. False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease.
Weinblatt ME; Zanzi I; Belakhlef A; Babchyck B; Kochen J
J Nucl Med; 1997 Jun; 38(6):888-90. PubMed ID: 9189136
[TBL] [Abstract][Full Text] [Related]
8. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.
Böni R; Böni RA; Steinert H; Burg G; Buck A; Marincek B; Berthold T; Dummer R; Voellmy D; Ballmer B
Br J Dermatol; 1995 Apr; 132(4):556-62. PubMed ID: 7748746
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of thymic uptake at 18F-FDG PET.
Ferdinand B; Gupta P; Kramer EL
Radiographics; 2004; 24(6):1611-6. PubMed ID: 15537971
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK
Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy.
Kawano T; Suzuki A; Ishida A; Takahashi N; Lee J; Tayama Y; Oka T; Yokota S; Inoue T
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):831-6. PubMed ID: 14963698
[TBL] [Abstract][Full Text] [Related]
12. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT.
Nakahara T; Fujii H; Ide M; Nishiumi N; Takahashi W; Yasuda S; Shohtsu A; Kubo A
Br J Radiol; 2001 Sep; 74(885):821-4. PubMed ID: 11560830
[TBL] [Abstract][Full Text] [Related]
13. The frequency and spectrum of thymus 2-[fluorine-18] fluoro-2-deoxy-D-glucose uptake patterns in hyperthyroidism patients.
Chen YK; Yeh CL; Chen YL; Wang SC; Cheng RH; Kao PF
Acad Radiol; 2011 Oct; 18(10):1292-7. PubMed ID: 21893295
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
[TBL] [Abstract][Full Text] [Related]
15. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans.
Zasadny KR; Kison PV; Quint LE; Wahl RL
Radiology; 1996 Dec; 201(3):873-6. PubMed ID: 8939245
[TBL] [Abstract][Full Text] [Related]
16. FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET.
Macfarlane DJ; Shulkin BL; Murphy K; Wolf GT
Eur J Nucl Med; 1995 Nov; 22(11):1347-50. PubMed ID: 8575489
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET in pediatric posterior fossa brain tumors.
Hoffman JM; Hanson MW; Friedman HS; Hockenberger BM; Oakes WJ; Halperin EC; Coleman RE
J Comput Assist Tomogr; 1992; 16(1):62-8. PubMed ID: 1729308
[TBL] [Abstract][Full Text] [Related]
18. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
[TBL] [Abstract][Full Text] [Related]
19. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
20. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S
J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
